Research
Biological Warfare
Biological Warfare Emerges As 21st-Century Threat
BY MARK SHWARTZ January 11,
2001
Why is biophysicist Steven
Block so concerned about smallpox?
After all, more than 20 years
have passed since the World Health Organization (WHO) announced
the eradication of this highly contagious and incurable
disease.
"Simply put, smallpox
represents a direct threat to the entire world," says
Block, a professor of biological sciences and applied physics,
who joined the Stanford faculty from Princeton in 1999.
He points out that, although
the disease has been eliminated in the wild, frozen stocks
of smallpox virus are still maintained by the governments
of the United States and Russia.
If rogue politicians or terrorists
were to get hold of the remaining supplies, "the consequences
could be disastrous," he warns. |
|

US
military personnel don special biohazard gear during
a training exercise designed to simulate a biological
weapons attack. The Department of Defense and other
agencies routinely hold training sessions throughout
the country as part of a domestic bioterrorism preparedness
program. "The challenge is to integrate these forces
to mount an effective response under various attack
scenarios," says Prof. Steven Block. COURTESY:
US Navy
|
But Block is haunted by more
than the threat of a smallpox attack.
He points to some two dozen
conventional biological agents -- including anthrax, Ebola and
typhus -- plus an unknown number of genetically engineered organisms
that terrorists could unleash on an unsuspecting public.
"We're tempted to say
that nobody in their right mind would ever use these things,"
he says, "but not everybody is in their right mind!"
Block paints a disturbing
picture of the international bioterrorist threat in an article
published in the Jan./Feb. issue of American Scientist
magazine.
His expertise in biological
warfare stems from his work with JASON, an organization of primarily
academic scientists who dedicate a portion of their time to solving
national security problems. Members of JASON often serve as consultants
to the Defense Department and other U.S. agencies
"In my opinion,"
he writes, "the terrorist threat is very real, and it's about
to get worse."
Block argues that the United
States and other developed countries should be doing more to prevent
the spread of biological weaponry. He saves his harshest criticism
for his fellow biologists, most of whom have remained silent on
the issue.
"Where are the biological
scientists willing to go on the record about bioweapons?"
he asks.
Anthrax
Biological weapons are "the
poor man's atom bomb," writes Block in American Scientist.
He argues that bioweapons
offer terrorist groups and "rogue states" (such as Iraq
and North Korea) an affordable way to counter the overwhelming
military superiority of the United States and other nuclear powers.
The agent of choice for most
biological warfare programs, writes Block, is anthrax. Anthrax
bacteria produce extremely lethal spores, and breathing in large
numbers can lead to inhalation anthrax --- a disease that usually
is fatal unless treated with large doses of a penicillin-type
antibiotic immediately after exposure.
Anthrax spores are easy to
produce and can remain viable for more than 100 years if kept
dry and out of direct sunlight.
Their long shelf life makes
them "well suited to weaponization in a device that can deliver
a widespread aerosol," Block notes.
Anthrax also is relatively
easy and safe to handle. "Anthrax is not very communicable,"
he writes, "thereby reducing the risk that it will spread
beyond the intended target. Moreover, a well-established vaccine
exists that can prevent the onset of the disease, allowing it
to be used safely by the aggressor."
"Black biology"
If anthrax, smallpox and
other "conventional" biological agents aren't frightening
enough, Block also raises the specter of "black biology"
--- a shadowy science in which microorganisms are genetically
engineered for the sole purpose of creating novel weapons of terror.
"The idea that anybody
can brew this stuff in their garage vastly overstates the case,"
he says, "but any technology that can be used to insert genes
into DNA can be used for either good or bad."
Block points out that genetic
maps of deadly viruses, bacteria and other microorganisms already
are widely available in the public domain. Any scientist bent
on destruction could use this information to attempt to clone
extremely virulent strains of bacteria and viruses, Block contends.
He notes that there are plenty
of underpaid microbiologists in the world who might be eager to
work for unscrupulous clients to produce incurable "designer
diseases," such as penicillin-resistant anthrax, or "stealth
viruses" that infect the host but remain silent until activated
by some external trigger.
History lessons
Biological warfare is as
old as civilization, observes Block, but it was international
revulsion over the widespread use of poisonous mustard gas during
World War I that finally led to a 1925 treaty banning bioweapons
during future wars.
During World War II, the
Japanese military killed thousands of Chinese prisoners by subjecting
them to experimental doses of anthrax, cholera, plague and other
pathogens.
After World War II, the United
States and the Soviet Union launched full-scale bioweapons programs,
which included the development of aerosol sprays capable of delivering
bacterial and viral agents by plane or ballistic missile.
"Both sides also stockpiled
plenty of anthrax," adds Block.
In 1969, President Richard
Nixon issued an executive order unilaterally and unconditionally
ending America's bioweapons program, and all U.S. stockpiles were
destroyed by 1972.
That same year, 160 nations
signed a treaty banning all use of biological and chemical weapons;
143 countries eventually ratified the treaty, including the United
States, Russia, Iraq, Iran, Libya and North Korea.
Failed treaty
Despite its noble intentions,
says Block, the 1972 treaty lacks any significant provisions for
enforcement or verification. As a result, a number of signatories
to the treaty have maintained active bioweapons programs.
"I'm fairly confident
that the U.S. has stopped producing biological weapons,"
he says, "but the Soviet Union carried out ultra-secret bioweapons
work right up until it collapsed in 1990."
In 1979, 100 people and countless
livestock died following the accidental release of anthrax spores
from a bioweapons plant in the Russian city of Sverdlovsk ---
one of 40 such facilities that operated in the former Soviet Union.
Russia's dismal economic
situation raises the question of how out-of-work bioweapons scientists
are managing to find gainful employment now, observes Block.
"Some experts contend
that a low but significant level of bioresearch still exists today,"
he adds.
Block's ultimate nightmare
is that terrorists somehow could get access to the smallpox viruses
being kept on ice in Russia -- a fear bolstered by the testimony
of a former official in the Russian biowarfare program, who claimed
that smallpox-based weapons were being manufactured there as recently
as 1992.
Iraq also has violated the
1972 bioweapons treaty by mass-producing weapons-grade anthrax
and conducting research on a wide variety of other biological
agents. Details of the Iraqi bioweaponry program only came to
light in the aftermath of the 1991 Gulf War.
All told, Block estimates
that about a dozen countries are believed to have active bioweapons
programs.
Terrorist threat
Although Block is concerned
about the bioweapons buildup in Iraq and other nations, he believes
a greater threat comes from terrorist groups willing to risk an
out-of-control epidemic and eager to suffer casualties for the
good of "the cause."
A recent example was the
1995 sarin gas attack inside the Tokyo subway by the Japanese
apocalyptic cult Aum Shinrikyo. The widely publicized assault,
which killed 13 people and hospitalized thousands, had been preceded
by a series of failed botulism and anthrax assaults near the Imperial
Palace, a Tokyo airport and two U.S. military bases.
"Groups like Aum Shinrikyo
are willing to use biological agents inefficiently just for the
terror and propaganda value," Block contends.
Solutions
During fiscal year 2000,
the Clinton administration allocated $1.4 billion to combat both
biological and chemical warfare -- a good beginning but not enough,
according to Block, who believes more should be spent beefing
up America's anti-terrorist intelligence effort and its emergency
response capability.
Block also supports the development
of high-tech devices capable of instantaneously detecting lethal
bacteria and viruses in the environment, and he encourages the
production and stockpiling of new vaccines -- a hot-button issue
in Washington, D.C., these days.
The anthrax vaccine has stirred
the most controversy. The U.S. military wants to inoculate all
2.4 million active and reserve troops, but no one knows if the
current vaccine will provide immunity against inhalation anthrax
-- the type commonly used in bioweapons.
As for smallpox, routine
vaccinations in the United States ended in 1980, the year the
virus was officially eradicated, so few Americans still have immunity
today. The Centers for Disease Control will make 40 million new
doses of the vaccine available beginning in 2004, but critics
say that, in the event of a multi-city terrorist attack, hundreds
of millions of doses will be needed to prevent the often-fatal
disease from spreading throughout the country.
On the diplomatic front,
Block argues in favor of strengthening the 1972 bioweapons treaty
--- "giving it some 'teeth,'" he says, by requiring
reciprocal international inspections to assure treaty compliance.
"Embarrassingly,"
he notes, "the United States itself has steadfastly resisted
certain attempts to establish provisions for inspections"
-- in part to protect the interests of large American pharmaceutical
and biotech companies against industrial espionage.
He also makes a strong plea
to his fellow biologists to break their silence and take a stand
against the proliferation of biological weapons.
"Some folks simply do
not take the threat seriously," he observes, "but they
should. Others worry about provoking a widespread public backlash
against biotechnology in general that might have a chilling effect
on their own legitimate biological research."
None of these excuses stands
up to close scrutiny, Block contends, adding that the time to
act is now before disaster strikes.
"We should not have
to wait for the biological equivalent of Hiroshima to rally our
defenses," he concludes.
This
story is a news release issued by Stanford University for journalists
and other members of the public. If you wish to quote from any
part of this story, please credit Stanford University as the original
source.
Next - Back
to Biological Warfare Research